The NeuroPoint Alliance and Your Practice: Using Registries to Enhance Quality, Reimbursement, Certification and Clinical Research
This online course explores the varied uses of registry data for patient care, quality improvement, clinical research, education and revenue enhancement. NPA initiatives, such as the Quality Outcomes Database (QOD) spine and cerebrovascular registries, the Registry for the Advancement of DBS Therapy in Parkinson’s Disease (RAD-PD) and the Stereotactic Radiosurgery Registry (SRS) are used to demonstrate how your organization can benefit from participation in these registries. This course benefits neurosurgeons, quality managers, clinical personnel and data coordinators.
Registration Fee
| AANS Members | $99 |
| Non-members | $139 |
| Attended 2018 Course | Free |
CME Credit
Earn up to 3.5 CME by participating.
Interested in the Live Course?
Click below to see information on the upcoming NeuroPoint and Your Practice live course taking place at the 2019 AANS Annual Scientific Meeting.
Learning Objectives
After completing this educational activity, participants should be able to:
- Determine how participation in NPA registry programs, and the use of registry data, can improve the quality of patient care and outcomes.
- Determine how participation in NPA registry programs, and the use of registry data, provides benchmarking information for use in cross-specialty quality assurance and improvement.
- Determine how participation in NPA registry programs can provide prospective and retrospective clinical research data for analysis.
- Determine how participation in NPA programs, and the use of registry data, can support reporting for alternative payment models and quality reporting requirements.
- Determine how NPA registry data can be used in payer contract negotiations.
Faculty Information
| Anthony L. Asher, MD, FAANS |
| Mohamad Bydon, MD |
| Kevin M. Cockroft, MD, FAANS |
| Clinton J. Devin, MD |
| Kevin T. Foley, MD, FAANS |
| Regis W. Haid Jr., MD, FAANS |
| Robert E. Harbaugh, MD, FAANS |
| John Joseph Knightly, MD, FAANS |
| Douglas S. Kondziolka, MD, FAANS |
| James McInerney, MD, FAANS |
| Debraj Mukherjee, MD |
| Praveen V. Mummaneni, MD, FAANS |
| Christopher I. Shaffrey, MD, FAANS |
| Jason P. Sheehan, MD, PhD, FAANS |
Planning Committee
Robert E. Harbaugh, MD, FAANS
Anthony L. Asher, MD, FAANS
Debraj Mukherjee, MD
Mohamad Bydon, MD
Jason P. Sheehan, MD, PhD
Kevin M. Cockroft, MD
Praveen V. Mummaneni, MD
DISCLOSURE INFORMATION
The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information. In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.
The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.
It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities. Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.
All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.
Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.
| Name | Relationship | Organization |
| Anthony Asher, MD | Hyperbranch Medical Technologies NeuroPoint Alliance ABNS | Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.) Consultant Fees Board/Trustee/Officer/Leadership position specifically with a neurosurgical or medical-related associated, non-profit or similar entity |
| Kevin M. Cockroft, MD | Medtronic Actuated Medical, Inc. Intersocietal Accreditation Commission | Consultant Fees Consultant Fees, Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.) Board/Trustee/Officer/Leadership position specifically with a neurosurgical or medical-related associated non-profit or similar entity |
| Clinton J. Devin, MD | Stryker Spine Penn State Grand Rounds Medtronic | Consultant Fees, Grants/Research Support Honorarium Other Financial Support |
| Kevin T. Foley, MD | Medtronic NuVasive, SpineWave Discgenics, TrueVision, DuraTap | Consultant Fees, Other Financial Support, Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.) Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.) Board/Trustee/Officer/Leadership position that could affect an entities' finances, Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.) |
| Regis W. Haid Jr., MD | NuVasive Globus Medical, Medtronic Sofamor Danek, Elsevier, Inc. NuVasive, Spine Wave, Vertical Health | Consultant Fees Other Financial Support Stock Shareholder (purchased direct i.e. not through Mutual Fund,retirement package,etc.) |
| Robert E. Harbarugh, MD | Micromechatronics, Inc, Actuated Medical,
Inc., Cortex, Inc., Sidero Biosciences, LLC, Nanowear NuHope, LLC, NeuroPoint Alliance | Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.) Board/Trustee/Officer/Leadership position that could affect an entities' finances |
| Douglas S. Kondziolka, MD | Brainlab, Neuropoint Alliance AANS (Journal of Neurosurgery) | Grants/Research Support Other Financial Support |
| James McInerney, MD | Elekta Medtronic Abbott, Boston Scientific | Grants/Research Support Grants/Research Support, Honorarium Consultant Fees |
| Praveen V. Mummaneni, MD | Depuy spine UCSF Globus Thieme publishers, Springer publishing, Taylor and francis publshing Spinicity/ISD | Consultant Fees, Other Financial Support Employee (any industry) Consultant Fees Other Financial Support Stock Shareholder (purchased direct i.e. not through Mutual Fund,retirement package,etc.) |
| Christopher I. Shaffrey, MD | Medtronic Zimmer-Biomet Nuvasive K2M Stryker, NIH ISSG, AO, Department of Defense, NACTN | Consultant Fees, Grants/Research Support, Other Financial Support Other Financial Support Consultant Fees, Grants/Research Support, Other Financial Support, Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.) Consultant Fees,Grants/Research Support,Other Financial Support,Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.) Honorarium Grants/Research Support |
Those who have reported they do not have any relationships with commercial interests:
| Mohamad Bydon, MD |
| John Joseph Knightly, MD |
| Debraj Mukherjee, MD |
| Jason P. Sheehan, MD, PhD |
DISCLAIMER
The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.
Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve
ACCREDITATION/DESIGNATION
The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AANS designates this internet enduring material for a maximum of 3.5 AMA PRA Category 1 CreditTM.
Physicians should claim only credit commensurate with the extent of their participation in the activity.
Term of approval is for three years, beginning from 07/15/2018 to 07/15/2021.
Upon successful completion of the CME test, credit will automatically be reflected in your member record. NonMembers must print a certificate and retain a copy for your CME records.
Media utilized may include Adobe Flash.
Copyright © 2018 American Association of Neurological Surgeons
Key:
Complete
Next
Failed
Available
Locked